Skip to main content
Signal8

Saccomano Nicholas A

SEC insider (Form 3/4/5 filer). CIK 0001609284. President and CEO at OnKure Therapeutics, Inc. (OKUR). 22 reported Form 4/5 transactions since Sep 2024; latest on Sep 21, 2026. Located in BOULDER, CO.

Companies Saccomano Nicholas A has filed insider reports for

  • OnKure Therapeutics, Inc. (OKUR): Director, Officer, President and CEO
Saccomano Nicholas A profile photo

Saccomano Nicholas A

CIK: 0001609284

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)8 (36.4%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)9 (40.9%)

Compensation grants

Other (G, F, J, C, D, …)5 (22.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

OnKure Therapeutics, Inc. logo
OKUR

OnKure Therapeutics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (22 total)

  • OnKure Therapeutics, Inc. logo
    OKUR

    OnKure Therapeutics, Inc.

    Sep 21, 2026
    Sale
    Direct
    87 shares at avg. $2.97$258.755
  • OnKure Therapeutics, Inc. logo
    OKUR

    OnKure Therapeutics, Inc.

    Aug 7, 2026
    Award

    Employee Stock Option (right to buy)

    Direct
    8.4K shares-
  • OnKure Therapeutics, Inc. logo
    OKUR

    OnKure Therapeutics, Inc.

    Aug 7, 2026
    Disposition

    Employee Stock Option (right to buy)

    Direct
    8.4K shares-
  • OnKure Therapeutics, Inc. logo
    OKUR

    OnKure Therapeutics, Inc.

    Aug 7, 2026
    Disposition

    Employee Stock Option (right to buy)

    Direct
    1.5K shares-
  • OnKure Therapeutics, Inc. logo
    OKUR

    OnKure Therapeutics, Inc.

    Aug 7, 2026
    Disposition

    Employee Stock Option (right to buy)

    Direct
    16.9K shares-
  • OnKure Therapeutics, Inc. logo
    OKUR

    OnKure Therapeutics, Inc.

    Aug 7, 2026
    Award

    Employee Stock Option (right to buy)

    Direct
    1.5K shares-
  • OnKure Therapeutics, Inc. logo
    OKUR

    OnKure Therapeutics, Inc.

    Aug 7, 2026
    Award

    Employee Stock Option (right to buy)

    Direct
    2.4K shares-
  • OnKure Therapeutics, Inc. logo
    OKUR

    OnKure Therapeutics, Inc.

    Aug 7, 2026
    Disposition

    Employee Stock Option (right to buy)

    Direct
    2.4K shares-
  • OnKure Therapeutics, Inc. logo
    OKUR

    OnKure Therapeutics, Inc.

    Aug 7, 2026
    Award

    Employee Stock Option (right to buy)

    Direct
    150K shares-
  • OnKure Therapeutics, Inc. logo
    OKUR

    OnKure Therapeutics, Inc.

    Aug 7, 2026
    Award

    Employee Stock Option (right to buy)

    Direct
    16.9K shares-

1-10 of 22